Jeff Yass’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Jeff Yass’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66,400	Closed	-$1.32M	–	14629
2022 Q3	$1.32M	Buy	66,400 +14,400	+28%	+$190K	﹤0.01%	5905
2022 Q2	$358K	Buy	52,000 +2,000	+4%	+$14K	﹤0.01%	9082
2022 Q1	$465K	Buy	50,000 +39,400	+372%	+$419K	﹤0.01%	9176
2021 Q4	$151K	Buy	+10,600	New	+$183K	﹤0.01%	11786

Jeff Yass's FMTX Position: Q4 2022 in Review

Jeff Yass sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 13,647 shares — an estimated $272K sold.

Jeff Yass first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $1.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Jeff Yass reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Jeff Yass sold 13,647 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $272K.
Jeff Yass first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Jeff Yass's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.6M in Q1 2021.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.